Howard B Rosen - Net Worth and Insider Trading

Howard B Rosen Net Worth

The estimated net worth of Howard B Rosen is at least $3,524 dollars as of 2024-11-10. Howard B Rosen is the CEO of Talphera Inc and owns about 2,500 shares of Talphera Inc (TLPH) stock worth over $2,270. Howard B Rosen is also the Director of Kala Bio Inc and owns about 165 shares of Kala Bio Inc (KALA) stock worth over $1,254. Details can be seen in Howard B Rosen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Howard B Rosen has not made any transactions after 2019-05-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Howard B Rosen

To

Howard B Rosen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Howard B Rosen owns 2 companies in total, including Kala Bio Inc (KALA) , and Talphera Inc (TLPH) .

Click here to see the complete history of Howard B Rosen’s form 4 insider trades.

Insider Ownership Summary of Howard B Rosen

Ticker Comapny Transaction Date Type of Owner
KALA Kala Bio Inc 2019-05-30 director
TLPH Talphera Inc 2016-05-13 director

Howard B Rosen Latest Holdings Summary

Howard B Rosen currently owns a total of 2 stocks. Among these stocks, Howard B Rosen owns 2,500 shares of Talphera Inc (TLPH) as of May 13, 2016, with a value of $2,270 and a weighting of 64.42%. Howard B Rosen also owns 165 shares of Kala Bio Inc (KALA) as of May 30, 2019, with a value of $1,254 and a weighting of 35.58%.

Latest Holdings of Howard B Rosen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TLPH Talphera Inc 2016-05-13 2,500 0.91 2,270
KALA Kala Bio Inc 2019-05-30 165 7.60 1,254

Holding Weightings of Howard B Rosen


Howard B Rosen Form 4 Trading Tracker

According to the SEC Form 4 filings, Howard B Rosen has made a total of 0 transactions in Talphera Inc (TLPH) over the past 5 years. The most-recent trade in Talphera Inc is the acquisition of 510 shares on May 13, 2016, which cost Howard B Rosen around $33,272.

According to the SEC Form 4 filings, Howard B Rosen has made a total of 0 transactions in Kala Bio Inc (KALA) over the past 5 years. The most-recent trade in Kala Bio Inc is the acquisition of 100 shares on May 30, 2019, which cost Howard B Rosen around $27,100.

Insider Trading History of Howard B Rosen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Howard B Rosen Trading Performance

GuruFocus tracks the stock performance after each of Howard B Rosen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Howard B Rosen is -3.71%. GuruFocus also compares Howard B Rosen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Howard B Rosen within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Howard B Rosen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Howard B Rosen

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.12 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 3.58 LIMIT LIMIT LIMIT LIMIT LIMIT

Howard B Rosen Ownership Network

Ownership Network List of Howard B Rosen

No Data

Ownership Network Relation of Howard B Rosen

Insider Network Chart

Howard B Rosen Owned Company Details

What does Kala Bio Inc do?

Who are the key executives at Kala Bio Inc?

Howard B Rosen is the director of Kala Bio Inc. Other key executives at Kala Bio Inc include CHIEF BUSINESS OFFICER Darius Kharabi , director & Chief Executive Officer Mark T Iwicki , and Chief Financial Officer Mary Reumuth .

Kala Bio Inc (KALA) Insider Trades Summary

Over the past 18 months, Howard B Rosen made no insider transaction in Kala Bio Inc (KALA). Other recent insider transactions involving Kala Bio Inc (KALA) include a net sale of 27,099 shares made by Mark T Iwicki , a net sale of 9,108 shares made by Romulus K Brazzell , and a net sale of 8,151 shares made by Todd Bazemore .

In summary, during the past 3 months, insiders sold 0 shares of Kala Bio Inc (KALA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 59,535 shares of Kala Bio Inc (KALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 59,535 shares.

Kala Bio Inc (KALA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kala Bio Inc Insider Transactions

No Available Data

Howard B Rosen Mailing Address

Above is the net worth, insider trading, and ownership report for Howard B Rosen. You might contact Howard B Rosen via mailing address: C/o Acelrx Pharmaceuticals, Inc., 351 Galveston Drive, Redwood City Ca 94063.